Clinical Effect of Two Pharmacokinetics Model of Propofol

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Interventions
DRUG

Evaluation of propofol effect

"The study will make in two stages:~STAGE I: All volunteers will receive propofol infusion with the first model randomly chosen (Schnider or Cortinez) using TCI device, and the initial effect-site target concentration of propofol will be 3 ug/ml for 20 minutes."

DRUG

Evaluation of propofol effect

STAGE II: 72 hours after stage I . All volunteers will receive propofol infusion with the first model randomly chosen (Schnider or Cortinez) using TCI devices, and the initial effect-site target concentration of propofol will be 3 ug/ml for 20 minutes.

Trial Locations (1)

Unknown

Clinica Avila, Caracas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic - MITG

INDUSTRY

lead

Tiva Group

OTHER

NCT02155517 - Clinical Effect of Two Pharmacokinetics Model of Propofol | Biotech Hunter | Biotech Hunter